POLE c.2218del ;(p.E740Kfs*52)

Variant ID: 12-133244189-TC-T

NM_006231.2(POLE):c.2218del;(p.E740Kfs*52)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.

Jco Precision Oncology
Garmezy, Benjamin B; Gheeya, Jinesh J; Lin, Heather Y HY; Huang, Yuefan Y; Kim, Taebeom T; Jiang, Xianli X; Thein, Kyaw Z KZ; PiliƩ, Patrick G PG; Zeineddine, Fadl F; Wang, Wanlin W; Shaw, Kenna R KR; Rodon, Jordi J; Shen, John Paul JP; Yuan, Ying Y; Meric-Bernstam, Funda F; Chen, Ken K; Yap, Timothy A TA
Publication Date: 2022-02

Variant appearance in text: POLE: 2218del
PubMed Link: 35108036
Variant Present in the following documents:
  • po-6-e2100267.pdf
View BVdb publication page



Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.

Jco Precision Oncology
Garmezy, Benjamin B; Gheeya, Jinesh J; Lin, Heather Y HY; Huang, Yuefan Y; Kim, Taebeom T; Jiang, Xianli X; Thein, Kyaw Z KZ; PiliƩ, Patrick G PG; Zeineddine, Fadl F; Wang, Wanlin W; Shaw, Kenna R KR; Rodon, Jordi J; Shen, John Paul JP; Yuan, Ying Y; Meric-Bernstam, Funda F; Chen, Ken K; Yap, Timothy A TA
Publication Date: 2022-02

Variant appearance in text: POLE: 2218del
PubMed Link: 35108036
Variant Present in the following documents:
  • po-6-e2100267.pdf
View BVdb publication page